0.2 |
0.2 |
GO:0031952 |
regulation of protein autophosphorylation(GO:0031952) |
0.1 |
0.3 |
GO:0033023 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 |
0.3 |
GO:1904744 |
positive regulation of telomeric DNA binding(GO:1904744) |
0.1 |
0.2 |
GO:0015728 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.1 |
0.5 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
0.1 |
0.2 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) regulation of centriole elongation(GO:1903722) |
0.1 |
0.2 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
0.0 |
0.1 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
0.0 |
0.2 |
GO:0009956 |
radial pattern formation(GO:0009956) |
0.0 |
0.1 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 |
0.1 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 |
0.1 |
GO:0061534 |
gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.0 |
0.1 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
0.0 |
0.2 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
0.0 |
0.2 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
0.0 |
0.2 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
0.0 |
0.2 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 |
0.2 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
0.0 |
0.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
0.0 |
0.4 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 |
0.2 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
0.0 |
0.2 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
0.0 |
0.1 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
0.0 |
0.1 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
0.0 |
0.2 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
0.0 |
0.1 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.0 |
0.1 |
GO:0002545 |
chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
0.0 |
0.3 |
GO:0046836 |
glycolipid transport(GO:0046836) |
0.0 |
0.1 |
GO:0043553 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 |
0.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 |
0.1 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 |
0.1 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
0.0 |
0.2 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
0.0 |
0.1 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.0 |
0.1 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.0 |
0.1 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.0 |
0.1 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.0 |
0.2 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
0.0 |
0.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
0.0 |
0.1 |
GO:0035261 |
external genitalia morphogenesis(GO:0035261) |
0.0 |
0.1 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.0 |
0.1 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
0.0 |
0.1 |
GO:1990051 |
activation of protein kinase C activity(GO:1990051) |
0.0 |
0.1 |
GO:0060488 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.0 |
0.2 |
GO:0034670 |
chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.0 |
0.1 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
0.0 |
0.1 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
0.0 |
0.1 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 |
0.1 |
GO:0032849 |
positive regulation of cellular pH reduction(GO:0032849) |
0.0 |
0.1 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 |
0.1 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
0.0 |
0.2 |
GO:0030500 |
regulation of bone mineralization(GO:0030500) |
0.0 |
0.1 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.0 |
0.4 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
0.0 |
0.1 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
0.0 |
0.1 |
GO:0048936 |
visceral motor neuron differentiation(GO:0021524) peripheral nervous system neuron axonogenesis(GO:0048936) cardiac cell fate determination(GO:0060913) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
0.0 |
0.1 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
0.0 |
0.1 |
GO:1904382 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 |
0.1 |
GO:1901377 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.0 |
0.1 |
GO:0045829 |
negative regulation of isotype switching(GO:0045829) |
0.0 |
0.1 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 |
0.1 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
0.0 |
0.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 |
0.2 |
GO:1901315 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 |
0.1 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
0.0 |
0.1 |
GO:0002176 |
male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.0 |
0.3 |
GO:0045116 |
protein neddylation(GO:0045116) |
0.0 |
0.1 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 |
0.2 |
GO:0019367 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 |
0.1 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 |
0.2 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
0.0 |
0.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 |
0.0 |
GO:0002352 |
B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 |
0.1 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.0 |
0.2 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 |
0.3 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 |
0.1 |
GO:1904502 |
lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.0 |
0.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
0.0 |
0.1 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 |
0.4 |
GO:0002347 |
response to tumor cell(GO:0002347) |
0.0 |
0.2 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
0.0 |
0.1 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
0.0 |
0.2 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
0.0 |
0.1 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
0.0 |
0.4 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
0.0 |
0.1 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
0.0 |
0.3 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 |
0.1 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
0.0 |
0.1 |
GO:0061055 |
myotome development(GO:0061055) |
0.0 |
0.1 |
GO:1901727 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) protein kinase D signaling(GO:0089700) positive regulation of histone deacetylase activity(GO:1901727) |
0.0 |
0.1 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
0.0 |
0.0 |
GO:0051029 |
rRNA transport(GO:0051029) |
0.0 |
0.1 |
GO:0035802 |
adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
0.0 |
0.1 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
0.0 |
0.1 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 |
0.1 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
0.0 |
0.1 |
GO:1902164 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.0 |
0.1 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
0.0 |
0.1 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |